CDMO for EMBED 3.0 Research Study
- Cardiff University
Procurement identifier (OCID): ocds-h6vhtk-068b66
Description
Due to the highly specific technical requirements regarding product manufacture (microinjection-moulding (MIM) of formulations containing API) it rapidly became clear that we needed to separate the production from the clinical trial services and identify separate vendors for these services. At the current stage of the program, the identification and selection of a Contract Development and Manufacturing Organization (CDMO) was prioritized by the EMBED team and the funder.
Notices
UK6: Contract award notice
- Notice identifier
- 2026/S 000-038100
- Published
- 27 April 2026, 2:40pm
UK5: Transparency notice
- Notice identifier
- 2026/S 000-037949
- Published
- 27 April 2026, 11:31am